Article Details
Retrieved on: 2024-06-01 15:12:07
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses Arbutus Biopharma Co.'s stock performance, emphasizing institutional investors' increased holdings and analysts' target prices. It highlights the company's focus on Hepatitis B therapeutics. Tags and key concept directly relate to the company's focus and stock activities in the biopharma sector.
Article found on: www.defenseworld.net
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here